Featured news in The Life Sciences Report



Cesca Therapeutics Inc. (KOOL:NASDAQ)
Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25 (3/20/2019)

view
 


Athersys Inc. ()
What Makes Athersys (ATHX) a New Buy Stock (3/19/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Allergan's Anti-Infective Gets FDA Nod for Pediatric Patients (3/19/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse (3/19/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
The Zacks Analyst Blog Highlights: Hilton, Xilinx, Quanta, Anthem and Celgene (3/20/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
PhaseBio Stock Up on Positive Data From PB2452 Phase I Study (3/19/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Puma Biotech's (PBYI) Nerlynx Gets Approval in Australia (3/19/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Buy These 5 ROE Stocks as Stock Market Euphoria Continues (3/20/2019)

view
 


ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
ProMIS Neurosciences to Present Data for Potential Best-in-Class Antibody Candidates for Parkinson's Disease at AD/PD(TM) 2019 Conference (3/19/2019)

view
 


Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
420 with CNW - Two New Jersey Committees Voted on Marijuana Legalization Today (3/18/2019)

view
 


RepliCel Life Sciences Inc. (RP:TSX.V; REPCF:OTCQB)
RepliCel Reignites its First-in-Japan Strategy (3/19/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Bristol-Myers & Pfizer Release Phase IV Data on Eliquis (3/18/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Are Americans More Confident in 2019? 5 Top Picks (3/19/2019)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Atlas Blockchain Announces Definitive Agreement for the Acquisition of Isracann and Amendment to Investor Services Agreement (3/18/2019)

view
 


Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Sproutly Announces Premium Recreational Cannabis Flower Brand: Caliber (3/18/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Bear of the Day: Gilead Sciences (GILD) (3/18/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
AstraZeneca Up This Year on New Drugs & Pipeline Progress (3/18/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Lexicon Pharma Initiates Dosing in Biliary Tract Cancer Study (3/18/2019)

view